[ACRV] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[ACRV] Acrivon Therapeutics, Inc. Common Stock
Announcement Date
28-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -103.48%
Quarter Report
ACRV's Result
ACRV's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
Revenue 0 0 0 0 -
PBT -60,388 -31,167 -16,243 -5,306 124.93%
Tax 0 -1,490 -200 -193 -
NP -60,388 -29,677 -16,243 -5,306 124.93%
Tax Rate - - - - -
Total Cost 60,388 29,677 16,243 5,306 124.93%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
EPS -2.74 -1.35 -0.78 -0.25 122.12%
EPS Diluted -2.74 -1.35 -0.78 -0.25 122.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.